TIBER CREEK GROUP for EMD SERONO, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues relating to In Vitro Fertilization (IVF); S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022; HR 7667 - Food and Drug Amendments of 2022; Consolidated Appropriations Act, 2023 (PL 117-328), Division FF, Title III - Food and Drug Administration, Subtitle B - Drugs and Biologics and Subtitle F, Chapter 1 - Clinical Trial Diversity and Modernization.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| COREY MALMGREN | — |
Medicare/Medicaid MMM
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act (PL 117-169); Issues relating to Part D pricing reform; issues relating to Medicare Part D and Part B Pricing Reform; Issues related to capping out-of-pocket costs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| COREY MALMGREN | — |
Budget/Appropriations BUD
Issues related to the VA infertility coverage benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LEFFINGWELL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.